Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
6622.HK
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.23
N/A
-0.25
vs -0.18
Q2.23
N/A
-0.23
vs -0.17
Q3.23
N/A
-0.15
vs -0.25
Q4.23
N/A
-0.15
vs -0.26
Q1.24
N/A
-0.08
vs -0.25
Q2.24
N/A
-0.07
vs -0.23
Q3.24
N/A
-0.16
vs -0.15
Q4.24
N/A
-0.16
vs -0.15
Q1.25
N/A
-0.27
vs -0.08
Q2.25
N/A
-0.26
vs -0.07
Sales Growth
YoY
Current
Estimates
Q1.23
NA
5.7M vs NA
Q2.23
NA
5.7M vs NA
Q3.23
NA
3.7M vs NA
Q4.23
NA
3.7M vs NA
Q1.24
+340%
24.9M vs 5.7M
Q2.24
+340%
24.9M vs 5.7M
Q3.24
+163%
9.8M vs 3.7M
Q4.24
+163%
9.8M vs 3.7M
Q1.25
-58%
10.3M vs 24.9M
Q2.25
-56%
10.9M vs 24.9M
Return on Equity
QoQ
Q1.23
-5%
-0.05
vs -0.05
Q2.23
-5%
-0.05
vs -0.05
Q3.23
-4%
-0.04
vs -0.05
Q4.23
-4%
-0.04
vs -0.04
Q1.24
-2%
-0.02
vs -0.04
Q2.24
-2%
-0.02
vs -0.02
Q3.24
-4%
-0.04
vs -0.02
Q4.24
-4%
-0.04
vs -0.04
Institutionnal Ownership
Forecast
2519%2025-Revenue
-532%2025-EPS
163%2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Relative Strength
6622.HK
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company, engages in the research, development, and commercialization of therapies that address unmet medical needs in the People's Republic of China. It is developing various drugs that cover ophthalmic indications affecting the anterior and posterior segments, including dry eye diseases, wet age-related macular degeneration, diabetic macular edema, myopia, and glaucoma. The company was formerly known as China Ophthalmology Focus Limited. Zhaoke Ophthalmology Limited was incorporated in 2017 and is headquartered in Guangzhou, the People's Republic of China.
HKSE
Unprofitable
Unprofitable
0.06Â ( 2.29%)
Relative Strenght
Volume Buzz
2%
Earning Acce
No
Dist 52w H.
26%Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 6622.HK compares to sector?